FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Behzod Dolimbek

Research Profile

Chemicals & Drugs

Living Beings

Genes & Molecular Sequences

Amino Acid Sequences

Concepts & Ideas

Disorders

Torticollis

Procedures

Anatomy

Co-author Network

Publications

TOP 3
Tolga Eichhorn; Katharina Deeg; Behzod Z Dolimbek; Thomas Efferth; M Zouhair Atassi
Inhibition in vivo of the activity of botulinum neurotoxin A by small molecules selected by virtual screening.
M Zouhair Atassi; Behzod Z Dolimbek; Lance E Steward; K Roger Aoki
Antibodies against a synthetic peptide designed to mimic a surface area of the H chain of botulinum neurotoxin A.
M Zouhair Atassi; Behzod Z Dolimbek; Minako Oshima; K Roger Aoki
Antibody and T cell recognition of the light chain of botulinum neurotoxin A in two high-responder mouse strains.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Behzod Dolimbek (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Tolga Eichhorn; Katharina Deeg; Behzod Z Dolimbek; Thomas Efferth; M Zouhair Atassi
Inhibition in vivo of the activity of botulinum neurotoxin A by small molecules selected by virtual screening.
Toxicon : official journal of the International Society on Toxinology 2012;60(6):1180-90.
2012: M Zouhair Atassi; Behzod Z Dolimbek; Lance E Steward; K Roger Aoki
Antibodies against a synthetic peptide designed to mimic a surface area of the H chain of botulinum neurotoxin A.
Immunology letters 2012;142(1-2):20-7.
2012: M Zouhair Atassi; Behzod Z Dolimbek; Minako Oshima; K Roger Aoki
Antibody and T cell recognition of the light chain of botulinum neurotoxin A in two high-responder mouse strains.
Immunobiology 2012;217(1):1-7.
2012: M Zouhair Atassi; Joseph Jankovic; Lance E Steward; K Roger Aoki; Behzod Z Dolimbek
Molecular immune recognition of botulinum neurotoxin B. The light chain regions that bind human blocking antibodies from toxin-treated cervical dystonia patients. Antigenic structure of the entire BoNT/B molecule.
Immunobiology 2012;217(1):17-27.
2011: M Zouhair Atassi; Behzod Z Dolimbek; Joseph Jankovic; Lance E Steward; K Roger Aoki
Regions of botulinum neurotoxin A light chain recognized by human anti-toxin antibodies from cervical dystonia patients immunoresistant to toxin treatment. The antigenic structure of the active toxin recognized by human antibodies.
Immunobiology 2011;216(7):782-92.
2011: Behzod Z Dolimbek; K Roger Aoki; M Zouhair Atassi
Reduction of antibody response against botulinum neurotoxin A by synthetic monomethoxypolyethylene glycol-peptide conjugates.
Immunology letters 2011;137(1-2):46-52.
2011: Behzod Z Dolimbek; Lance E Steward; K Roger Aoki; M Zouhair Atassi
Regions of recognition by blocking antibodies on the light chain of botulinum neurotoxin A: antigenic structure of the entire toxin.
Immunobiology 2011;216(6):698-706.
2010: M Zouhair Atassi; Behzod Z Dolimbek; Lance Steward; K Roger Aoki
Inhibition of botulinum neurotoxin a toxic action in vivo by synthetic synaptosome- and blocking antibody-binding regions.
The protein journal 2010;29(5):320-7.
2008: Behzod Z Dolimbek; Lance Steward; K Roger Aoki; M Zouhair Atassi
The binding sites on botulinum neurotoxin B for synaptotagmin and for blocking antibodies.
Biochemical and biophysical research communications 2008;376(3):631-2.
2008: M Zouhair Atassi; Joseph Jankovic; Behzod Z Dolimbek
Neutralizing antibodies in dystonic patients who still respond well to botulinum toxin type A.
Neurology 2008;71(13):1040; author reply 1040-1.
2008: M Zouhair Atassi; Behzod Z Dolimbek; Joseph Jankovic; Lance Steward; K Roger Aoki
Molecular recognition of botulinum neurotoxin B heavy chain by human antibodies from cervical dystonia patients that develop immunoresistance to toxin treatment.
Molecular immunology 2008;45(15):3878-88.
2008: Behzod Z Dolimbek; Lance Steward; K Roger Aoki; M Zouhair Atassi
Immune recognition of botulinum neurotoxin B: antibody-binding regions on the heavy chain of the toxin.
Molecular immunology 2008;45(4):910-24.
2007: Behzod Z Dolimbek; K Roger Aoki; Lance Steward; Joseph Jankovic; M Zouhair Atassi
Mapping of the regions on the heavy chain of botulinum neurotoxin A (BoNT/A) recognized by antibodies of cervical dystonia patients with immunoresistance to BoNT/A.
Molecular immunology 2007;44(5):1029-41.
2007: M Zouhair Atassi; Behzod Z Dolimbek; Lance Steward; K Roger Aoki
Molecular bases of protective immune responses against botulinum neurotoxin A--how antitoxin antibodies block its action.
Critical reviews in immunology 2007;27(4):319-41.
2007: M Zouhair Atassi; Behzod Z Dolimbek; Philip R Deitiker; Joseph Jankovic; K Roger Aoki
A peptide-based immunoassay for antibodies against botulinum neurotoxin A.
Journal of molecular recognition : JMR 2007;20(1):15-21.
2006: Joseph Jankovic; Christine Hunter; Behzod Z Dolimbek; Gulnoz S Dolimbek; Charles H Adler; Allison Brashear; Cynthia L Comella; M Gordon; D E Riley; Kapil D Sethi; Carlos Singer; Mark Stacy; D Tarsy; M Zouhair Atassi
Clinico-immunologic aspects of botulinum toxin type B treatment of cervical dystonia.
Neurology 2006;67(12):2233-5.
2006: Takahiro Maruta; Behzod Z Dolimbek; K Roger Aoki; M Zouhair Atassi
Inhibition by human sera of botulinum neurotoxin-A binding to synaptosomes: a new assay for blocking and non-blocking antibodies.
Journal of neuroscience methods 2006;151(2):90-6.
2005: M Zouhair Atassi; Gulnoz S Dolimbek; Philip R Deitiker; K Roger Aoki; Behzod Z Dolimbek
Submolecular recognition profiles in two mouse strains of non-protective and protective antibodies against botulinum neurotoxin A.
Molecular immunology 2005;42(12):1509-20.
2005: Gulnoz S Dolimbek; Behzod Z Dolimbek; K Roger Aoki; M Zouhair Atassi
Mapping of the antibody and T cell recognition profiles of the HN domain (residues 449-859) of the heavy chain of botulinum neurotoxin A in two high-responder mouse strains.
Immunological investigations 2005;34(2):119-42.
2004: Takahiro Maruta; Behzod Z Dolimbek; K Roger Aoki; Lance Steward; M Zouhair Atassi
Mapping of the synaptosome-binding regions on the heavy chain of botulinum neurotoxin A by synthetic overlapping peptides encompassing the entire chain.
The protein journal 2004;23(8):539-52.
2004: M Zouhair Atassi; Behzod Z Dolimbek
Mapping of the antibody-binding regions on the HN-domain (residues 449-859) of botulinum neurotoxin A with antitoxin antibodies from four host species. Full profile of the continuous antigenic regions of the H-chain of botulinum neurotoxin A.
The protein journal 2004;23(1):39-52.
2002: Behzod Z Dolimbek; Joseph Jankovic; M Zouhair Atassi
Cross reaction of tetanus and botulinum neurotoxins A and B and the boosting effect of botulinum neurotoxins A and B on a primary anti-tetanus antibody response.
Immunological investigations 2002;31(3-4):247-62.